Balance Sheet Nutrien Ltd.

Equities

NTR

CA67077M1086

Agricultural Chemicals

Real-time Estimate TE Other stock markets 13:28:47 2026-01-16 EST			5-day change	1st Jan Change
92.26 ^CAD	-2.13%		+10.75%	+8.87%

07:21am	NUTRIEN : Jefferies is Neutral	ZD
01-14	Nutrien Shares Rise After Morgan Stanley Upgrade	MT

f0bd273.JpCxbPgQrhddg9YsWtw7FWnyAN5gei-JPZdY33JJzD8.YKjeVYpT_XE50rlEF65-TSi5eqYOPXX4dsI1uSok-lIUqdgcvkPGTyrQ4g

Published financial data: NUTRIEN LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	20.05B	26.86B	37.01B	28.08B	25.02B
Total Revenues	20.05B	26.86B	37.01B	28.08B	25.02B
Cost of Goods Sold, Total	14.81B	17.45B	21.59B	19.61B	17.49B
Gross Profit	5.24B	9.41B	15.42B	8.47B	7.53B
Selling General & Admin Expenses, Total	3.26B	3.63B	3.99B	4.03B	4.08B
Stock-Based Compensation (IS)	69M	198M	63M	-14M	37M
Other Operating Expenses	393M	737M	1.53B	907M	816M
Other Operating Expenses, Total	3.72B	4.56B	5.58B	4.92B	4.94B
Operating Income	1.52B	4.85B	9.84B	3.55B	2.59B
Interest Expense, Total	-475M	-479M	-484M	-726M	-683M
Interest And Investment Income	1M	8M	25M	35M	28M
Net Interest Expenses	-474M	-471M	-459M	-691M	-655M
Income (Loss) On Equity Invest.	73M	89M	247M	101M	130M
Currency Exchange Gains (Loss)	-18M	-42M	-31M	-91M	-360M
Other Non Operating Income (Expenses)	-33M	9M	-96M	-97M	-60M
EBT, Excl. Unusual Items	1.07B	4.43B	9.5B	2.78B	1.65B
Restructuring Charges	-	-	-	-	-47M
Merger & Related Restructuring Charges	-60M	-43M	-46M	-49M	-
Gain (Loss) On Sale Of Investments	250M	-	19M	-	-
Gain (Loss) On Sale Of Assets	-6M	-	-	-	-
Asset Writedown	-824M	-33M	780M	-774M	-530M
Insurance Settlements	-	-	-	-	65M
Other Unusual Items	-48M	-187M	-8M	-	-
EBT, Incl. Unusual Items	382M	4.17B	10.25B	1.95B	1.14B
Income Tax Expense	-77M	989M	2.56B	670M	436M
Earnings From Continuing Operations	459M	3.18B	7.69B	1.28B	700M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	459M	3.18B	7.69B	1.28B	700M
Minority Interest	-	-26M	-27M	-24M	-26M
Net Income - (IS)	459M	3.15B	7.66B	1.26B	674M
Net Income to Common Incl Extra Items	459M	3.15B	7.66B	1.26B	674M
Net Income to Common Excl. Extra Items	459M	3.15B	7.66B	1.26B	674M
Per Share Items
Net EPS - Basic	0.81	5.53	14.23	2.53	1.36
Basic EPS - Continuing Operations	0.81	5.53	14.23	2.53	1.36
Basic Weighted Average Shares Outstanding	570M	570M	538M	496M	494M
Net EPS - Diluted	0.81	5.52	14.18	2.53	1.36
Diluted EPS - Continuing Operations	0.81	5.52	14.18	2.53	1.36
Diluted Weighted Average Shares Outstanding	570M	571M	540M	497M	494M
Normalized Basic EPS	1.17	4.82	10.98	3.45	2.03
Normalized Diluted EPS	1.17	4.8	10.95	3.44	2.03
Dividend Per Share	1.8	1.84	1.92	2.12	2.16
Payout Ratio	224.4	33.14	13.46	82.03	157.27
Supplemental Items
EBITDA	3.23B	6.49B	11.51B	5.33B	4.51B
EBITA	1.8B	5.16B	10.21B	3.9B	2.93B
EBIT	1.52B	4.85B	9.84B	3.55B	2.59B
EBITDAR	3.29B	6.57B	11.61B	5.44B	4.62B
Effective Tax Rate - (Ratio)	-20.16	23.73	24.98	34.32	38.38
Total Current Taxes	-68M	1.02B	2.38B	663M	405M
Total Deferred Taxes	-9M	-31M	182M	7M	31M
Normalized Net Income	669M	2.74B	5.91B	1.71B	1B
Interest Capitalized	20M	29M	37M	71M	82M
Interest on Long-Term Debt	426M	448M	368M	494M	542M
Non-Cash Pension Expense	16M	19M	16M	-67M	-1M
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.81B	3.14B	3.41B	3.4B	3.44B
General and Administrative Expenses	429M	477M	565M	626M	644M
Research And Development Expense From Footnotes	39M	69M	122M	114M	124M
Net Rental Expense, Total	60M	81M	93M	103M	110M
Imputed Operating Lease Interest Expense	21.15M	29.65M	34.04M	53.62M	53.06M
Imputed Operating Lease Depreciation	38.85M	51.35M	58.96M	49.38M	56.94M
Stock-Based Comp., Other (Total)	69M	198M	63M	-14M	37M
Total Stock-Based Compensation	69M	198M	63M	-14M	37M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.45B	499M	901M	941M	853M
Total Cash And Short Term Investments	1.45B	499M	901M	941M	853M
Accounts Receivable, Total	3.02B	4.7B	5.6B	4.67B	4.64B
Other Receivables	562M	661M	598M	730M	755M
Total Receivables	3.58B	5.37B	6.19B	5.4B	5.39B
Inventory	4.93B	6.33B	7.63B	6.34B	6.15B
Prepaid Expenses	1.5B	1.65B	1.62B	1.5B	1.4B
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	11.47B	13.85B	16.34B	14.17B	13.79B
Gross Property Plant And Equipment	33.12B	34.82B	37.22B	39.32B	40.67B
Accumulated Depreciation	-13.46B	-14.8B	-15.46B	-16.86B	-18.07B
Net Property Plant And Equipment	19.66B	20.02B	21.77B	22.46B	22.6B
Long-term Investments	562M	703M	843M	736M	698M
Goodwill	12.2B	12.22B	12.37B	12.11B	12.04B
Other Intangibles, Total	2.39B	2.34B	2.3B	2.22B	1.82B
Deferred Tax Assets Long-Term	242M	262M	448M	477M	401M
Deferred Charges Long-Term	89M	88M	104M	113M	126M
Other Long-Term Assets, Total	583M	479M	417M	461M	357M
Total Assets	47.19B	49.95B	54.59B	52.75B	51.84B
Liabilities
Accounts Payable, Total	4.42B	5.18B	5.8B	5.48B	5.36B
Accrued Expenses, Total	1.34B	1.74B	1.78B	1.45B	1.28B
Short-term Borrowings	159M	1.56B	2.14B	1.82B	1.53B
Current Portion of Long-Term Debt	14M	545M	542M	512M	1.04B
Current Portion of Leases	249M	286M	305M	327M	356M
Current Income Taxes Payable	48M	606M	899M	14M	22M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	2.26B	2.53B	2.81B	2.53B	2.45B
Total Current Liabilities	8.48B	12.44B	14.28B	12.12B	12.04B
Long-Term Debt	10.05B	7.52B	8.04B	8.91B	8.88B
Long-Term Leases	891M	934M	899M	999M	999M
Pension & Other Post Retirement Benefits	454M	419M	319M	252M	227M
Deferred Tax Liability Non Current	3.15B	3.16B	3.55B	3.57B	3.54B
Other Non Current Liabilities	1.81B	1.77B	1.64B	1.69B	1.71B
Total Liabilities	24.83B	26.26B	28.72B	27.55B	27.4B
Common Stock, Total	15.67B	15.46B	14.17B	13.84B	13.75B
Additional Paid In Capital	205M	149M	109M	83M	68M
Retained Earnings	6.61B	8.19B	11.93B	11.53B	11.11B
Comprehensive Income and Other	-119M	-146M	-391M	-296M	-515M
Total Common Equity	22.36B	23.65B	25.82B	25.16B	24.41B
Minority Interest	-	47M	45M	45M	35M
Total Equity	22.36B	23.7B	25.86B	25.2B	24.44B
Total Liabilities And Equity	47.19B	49.95B	54.59B	52.75B	51.84B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	570M	551M	499M	495M	489M
ECS Total Common Shares Outstanding	569M	557M	507M	495M	491M
Book Value / Share	39.29	42.43	50.9	50.87	49.71
Tangible Book Value	7.78B	9.09B	11.15B	10.82B	10.54B
Tangible Book Value Per Share	13.67	16.31	21.99	21.89	21.48
Total Debt	11.36B	10.85B	11.93B	12.57B	12.81B
Net Debt	9.91B	10.35B	11.03B	11.62B	11.95B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-16M	-72M	-75M	-44M	-56M
Debt Equivalent Oper. Leases	480M	648M	744M	824M	880M
Minority Interest, Total (Incl. Fin. Div)	-	47M	45M	45M	35M
Equity Method Investments, Total	409M	459M	643M	482M	477M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	664M	823M	951M	884M	892M
Inventories - Work In Process, Total	227M	206M	184M	160M	154M
Inventories - Finished Goods, Total	4.04B	5.3B	6.5B	5.29B	5.1B
Land - (BS)	1.53B	1.55B	1.6B	1.63B	1.73B
Buildings, Total	8.38B	8.58B	8.8B	9.05B	9.19B
Machinery, Total	19.73B	20.63B	22.02B	23.24B	24.42B
Full Time Employees	23.1K	23.5K	24.7K	25.9K	25.5K
Accumulated Allowance for Doubtful Accounts (Supple)	69M	82M	95M	111M	167M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	459M	3.15B	7.66B	1.28B	674M
Depreciation & Amortization - CF	1.71B	1.64B	1.64B	1.83B	2B
Amortization of Goodwill and Intangible Assets - (CF)	283M	314M	368M	342M	341M
Depreciation & Amortization, Total	1.99B	1.95B	2.01B	2.17B	2.34B
(Gain) Loss on Sale of Investments - (CF)	-250M	-	-19M	-	-
Asset Writedown & Restructuring Costs	824M	33M	-780M	774M	530M
(Income) Loss On Equity Investments - (CF)	-	-	-181M	117M	-8M
Stock-Based Compensation (CF)	69M	198M	63M	-14M	37M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-342M	212M	503M	231M	450M
Change In Accounts Receivable	145M	-1.67B	-919M	879M	-224M
Change In Inventories	85M	-1.46B	-1.28B	1.38B	60M
Change In Accounts Payable	354M	1.69B	938M	-1.75B	-323M
Change in Other Net Operating Assets	-10M	-227M	114M	-	-
Cash from Operations	3.32B	3.89B	8.11B	5.07B	3.54B
Capital Expenditure	-1.42B	-1.68B	-2.23B	-2.46B	-2B
Cash Acquisitions	-233M	-88M	-407M	-153M	-21M
Divestitures	-	-	-	-92M	-
Sale (Purchase) of Intangible assets	-126M	-107M	-211M	-206M	-155M
Investment in Marketable and Equity Securities, Total	438M	-	-	-	-68M
Other Investing Activities, Total	140M	64M	-56M	-42M	110M
Cash from Investing	-1.2B	-1.81B	-2.9B	-2.96B	-2.13B
Short Term Debt Issued, Total	-	1.34B	529M	-	-
Long-Term Debt Issued, Total	1.54B	86M	1.04B	1.5B	1.02B
Total Debt Issued	1.54B	1.43B	1.57B	1.5B	1.02B
Short Term Debt Repaid, Total	-892M	-	-	-458M	-142M
Long-Term Debt Repaid, Total	-783M	-2.53B	-902M	-1.02B	-1.06B
Total Debt Repaid	-1.68B	-2.53B	-902M	-1.48B	-1.2B
Issuance of Common Stock	-	200M	168M	33M	18M
Repurchase of Common Stock	-160M	-1.04B	-4.52B	-1.05B	-184M
Common Dividends Paid	-1.03B	-1.04B	-1.03B	-1.03B	-1.06B
Common & Preferred Stock Dividends Paid	-1.03B	-1.04B	-1.03B	-1.03B	-1.06B
Other Financing Activities, Total	-15M	-21M	-20M	-34M	-46M
Cash from Financing	-1.34B	-3B	-4.73B	-2.06B	-1.45B
Foreign Exchange Rate Adjustments	3M	-31M	-76M	-7M	-37M
Net Change in Cash	783M	-955M	402M	40M	-88M
Supplemental Items
Cash Interest Paid	498M	491M	482M	729M	740M
Cash Income Tax Paid (Refund)	156M	435M	1.88B	1.76B	321M
Levered Free Cash Flow	1.76B	1.76B	4.63B	1.64B	1.36B
Unlevered Free Cash Flow	2.06B	2.06B	4.93B	2.09B	1.78B
Change In Net Working Capital	-599M	1.34B	855M	-388M	59M
Net Debt Issued / Repaid	-134M	-1.1B	672M	19M	-181M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.02	6.24	11.77	4.14	3.1
Return on Total Capital	2.81	8.87	17	5.88	4.32
Return On Equity %	2.03	13.79	31.02	5.02	2.82
Return on Common Equity	2.03	13.7	30.97	4.94	2.72
Margin Analysis
Gross Profit Margin %	26.13	35.03	41.67	30.18	30.1
SG&A Margin	16.23	13.51	10.77	14.34	16.33
EBITDA Margin %	16.12	24.16	31.11	18.99	18.04
EBITA Margin %	9	19.21	27.58	13.87	11.73
EBIT Margin %	7.59	18.04	26.59	12.65	10.37
Income From Continuing Operations Margin %	2.29	11.84	20.77	4.57	2.8
Net Income Margin %	2.29	11.74	20.7	4.48	2.69
Net Avail. For Common Margin %	2.29	11.74	20.7	4.48	2.69
Normalized Net Income Margin	3.33	10.21	15.97	6.09	4.01
Levered Free Cash Flow Margin	8.79	6.55	12.51	5.84	5.42
Unlevered Free Cash Flow Margin	10.27	7.66	13.33	7.45	7.13
Asset Turnover
Asset Turnover	0.43	0.55	0.71	0.52	0.48
Fixed Assets Turnover	1	1.35	1.77	1.27	1.11
Receivables Turnover (Average Receivables)	6.61	6.96	7.19	5.47	5.38
Inventory Turnover (Average Inventory)	2.99	3.1	3.09	2.81	2.8
Short Term Liquidity
Current Ratio	1.35	1.11	1.14	1.17	1.15
Quick Ratio	0.59	0.47	0.5	0.52	0.52
Operating Cash Flow to Current Liabilities	0.39	0.31	0.57	0.42	0.29
Days Sales Outstanding (Average Receivables)	55.36	52.48	50.79	66.7	68.05
Days Outstanding Inventory (Average Inventory)	122.36	117.73	118.01	130.01	130.65
Average Days Payable Outstanding	104.47	92.89	87.5	112.36	114.64
Cash Conversion Cycle (Average Days)	73.25	77.32	81.3	84.35	84.07
Long Term Solvency
Total Debt/Equity	50.79	45.77	46.12	49.86	52.4
Total Debt / Total Capital	33.68	31.4	31.56	33.27	34.38
LT Debt/Equity	48.91	35.68	34.56	39.33	40.42
Long-Term Debt / Total Capital	32.43	24.48	23.65	26.25	26.52
Total Liabilities / Total Assets	52.61	52.56	52.62	52.22	52.85
EBIT / Interest Expense	3.2	10.12	20.33	4.89	3.8
EBITDA / Interest Expense	7.39	14.19	24.49	7.88	7.22
(EBITDA - Capex) / Interest Expense	4.4	10.69	19.89	4.49	4.29
Total Debt / EBITDA	3.24	1.6	1.01	2.2	2.6
Net Debt / EBITDA	2.82	1.52	0.93	2.03	2.42
Total Debt / (EBITDA - Capex)	5.44	2.12	1.24	3.86	4.37
Net Debt / (EBITDA - Capex)	4.74	2.02	1.15	3.57	4.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.82	33.95	37.79	-24.13	-10.92
Gross Profit, 1 Yr. Growth %	-4.78	79.6	63.93	-45.06	-11.14
EBITDA, 1 Yr. Growth %	-10.37	100.8	77.4	-53.67	-15.41
EBITA, 1 Yr. Growth %	-21.59	185.87	97.83	-61.84	-24.67
EBIT, 1 Yr. Growth %	-25.43	218.4	103.05	-63.89	-27.02
Earnings From Cont. Operations, 1 Yr. Growth %	-53.73	592.59	141.81	-83.32	-45.4
Net Income, 1 Yr. Growth %	-53.73	586.93	142.94	-83.58	-46.42
Normalized Net Income, 1 Yr. Growth %	-29.88	310.22	115.47	-71.07	-41.3
Diluted EPS Before Extra, 1 Yr. Growth %	-52.6	585.08	156.88	-82.16	-46.25
Accounts Receivable, 1 Yr. Growth %	-0.92	55.85	18.94	-16.58	-0.71
Inventory, 1 Yr. Growth %	-0.9	28.36	20.61	-16.98	-2.97
Net Property, Plant and Equip., 1 Yr. Growth %	-3.32	1.81	8.75	3.19	0.64
Total Assets, 1 Yr. Growth %	0.84	5.85	9.27	-3.37	-1.72
Tangible Book Value, 1 Yr. Growth %	-8	16.88	22.67	-2.94	-2.59
Common Equity, 1 Yr. Growth %	-2.2	5.75	9.16	-2.56	-2.98
Cash From Operations, 1 Yr. Growth %	-9.33	16.94	108.7	-37.53	-30.22
Capital Expenditures, 1 Yr. Growth %	-17.65	17.78	25.32	9.41	-16.5
Levered Free Cash Flow, 1 Yr. Growth %	64.8	-0.23	177.65	-64.31	-20.65
Unlevered Free Cash Flow, 1 Yr. Growth %	49.7	-0.07	152.05	-57.25	-17.56
Dividend Per Share, 1 Yr. Growth %	2.27	2.22	4.35	10.42	1.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.36	17.92	35.86	2.25	-17.79
Gross Profit, 2 Yr. CAGR %	-1.43	30.77	71.58	-5.1	-30.13
EBITDA, 2 Yr. CAGR %	-7.32	34.16	88.74	-9.34	-37.4
EBITA, 2 Yr. CAGR %	-13.78	49.72	137.81	-13.12	-46.39
EBIT, 2 Yr. CAGR %	-16.27	54.09	154.27	-14.37	-48.67
Earnings From Cont. Operations, 2 Yr. CAGR %	284.79	79.02	309.23	-36.5	-69.82
Net Income, 2 Yr. CAGR %	-64.16	78.28	308.52	-36.83	-70.34
Normalized Net Income, 2 Yr. CAGR %	-20.62	69.6	197.31	-21.04	-58.79
Diluted EPS Before Extra, 2 Yr. CAGR %	301.43	80.2	319.51	-32.3	-69.03
Accounts Receivable, 2 Yr. CAGR %	4.85	24.26	36.15	-0.39	-8.99
Inventory, 2 Yr. CAGR %	0.13	12.78	24.42	0.06	-10.25
Net Property, Plant and Equip., 2 Yr. CAGR %	2.27	-0.79	5.22	5.93	1.9
Total Assets, 2 Yr. CAGR %	1.84	3.32	7.55	2.76	-2.55
Tangible Book Value, 2 Yr. CAGR %	-15.07	3.7	19.74	9.11	-2.76
Common Equity, 2 Yr. CAGR %	-4.31	1.7	7.44	3.13	-2.77
Cash From Operations, 2 Yr. CAGR %	27.26	2.97	56.22	14.18	-33.98
Capital Expenditures, 2 Yr. CAGR %	0.64	-1.52	25.1	17.78	-5.81
Levered Free Cash Flow, 2 Yr. CAGR %	36.76	28.23	62.08	-0.86	-45.65
Unlevered Free Cash Flow, 2 Yr. CAGR %	28.46	22.31	54.76	3.41	-39.64
Dividend Per Share, 2 Yr. CAGR %	5.09	2.25	3.28	7.34	6.07
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	71.01	12.69	24.21	11.88	-2.34
Gross Profit, 3 Yr. CAGR %	73.74	20.39	41	17.39	-7.16
EBITDA, 3 Yr. CAGR %	35.75	19.92	47.25	18.18	-11.41
EBITA, 3 Yr. CAGR %	43.18	28.57	64.29	29.22	-17.15
EBIT, 3 Yr. CAGR %	36.38	30.69	68.93	32.66	-18.82
Earnings From Cont. Operations, 3 Yr. CAGR %	43.91	368.07	97.89	40.83	-39.61
Net Income, 3 Yr. CAGR %	11.97	-4.08	97.65	39.94	-40.21
Normalized Net Income, 3 Yr. CAGR %	43.78	37.24	83.69	36.75	-28.47
Diluted EPS Before Extra, 3 Yr. CAGR %	64.81	379.72	102.8	46.43	-37.31
Accounts Receivable, 3 Yr. CAGR %	97.82	19.66	22.46	15.64	-0.5
Inventory, 3 Yr. CAGR %	84.26	8.77	15.33	8.72	-0.96
Net Property, Plant and Equip., 3 Yr. CAGR %	14.87	2.12	2.29	4.54	4.14
Total Assets, 3 Yr. CAGR %	40.55	3.16	5.26	3.78	1.24
Tangible Book Value, 3 Yr. CAGR %	-1.49	-5.53	9.67	11.64	5.07
Common Equity, 3 Yr. CAGR %	39.14	-1.07	4.13	4	1.05
Cash From Operations, 3 Yr. CAGR %	39.46	23.72	30.31	15.09	-3.11
Capital Expenditures, 3 Yr. CAGR %	29.78	6.06	8.82	20.1	4
Levered Free Cash Flow, 3 Yr. CAGR %	6.17	23.12	62.98	-2.39	-6.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.26	18.14	53.05	0.54	-3.04
Dividend Per Share, 3 Yr. CAGR %	65.1	4.12	2.94	5.61	5.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	28.2	46.94	55.97	8.39	5.31
Gross Profit, 5 Yr. CAGR %	18.22	60.73	72.87	9.46	6.48
EBITDA, 5 Yr. CAGR %	6.49	39.83	54.88	7.23	4.58
EBITA, 5 Yr. CAGR %	1.42	57.47	75.39	9.91	4.97
EBIT, 5 Yr. CAGR %	-1.9	56.33	74.97	10.35	4.9
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.26	74.06	118.6	110.53	-6.74
Net Income, 5 Yr. CAGR %	-18.42	57.73	87.9	-18.84	-7.44
Normalized Net Income, 5 Yr. CAGR %	-7.28	69.04	92.26	10.02	1.03
Diluted EPS Before Extra, 5 Yr. CAGR %	-9.63	87.66	139.49	119.19	-4.36
Accounts Receivable, 5 Yr. CAGR %	45.19	61.59	70.36	11.2	8.75
Inventory, 5 Yr. CAGR %	45.77	52.47	57.48	5.2	4.32
Net Property, Plant and Equip., 5 Yr. CAGR %	8.27	8.49	10.91	3.63	2.14
Total Assets, 5 Yr. CAGR %	21.99	23.69	26.28	3	2.07
Tangible Book Value, 5 Yr. CAGR %	-1.02	2.54	6.51	0.08	4.52
Common Equity, 5 Yr. CAGR %	21.69	23.6	25.47	0.59	1.31
Cash From Operations, 5 Yr. CAGR %	7.28	25.26	45.94	19.81	-0.72
Capital Expenditures, 5 Yr. CAGR %	3.18	13.42	27.89	11.9	2.96
Levered Free Cash Flow, 5 Yr. CAGR %	18.55	42.82	25.75	11.71	4.88
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.25	62.86	29.68	10.89	5.33
Dividend Per Share, 5 Yr. CAGR %	3.44	21.32	36.85	5.4	4.18